Merck & Co., Inc.MRKNYSE
LOADING
|||
Operating Expenses Over Time
Trending lower, above historical average, modest growth trend.
Left:
||||
Expenses from normal business operations (SG&A, R&D, etc.)
Latest
$28.75B
↑ 23% above average
Average (9y)
$23.44B
Historical baseline
Range
High:$41.03B
Low:$17.02B
CAGR
+6.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $28.75B | -29.9% |
| 2023 | $41.03B | +74.0% |
| 2022 | $23.59B | +7.8% |
| 2021 | $21.88B | -2.1% |
| 2020 | $22.35B | +16.5% |
| 2019 | $19.18B | -3.4% |
| 2018 | $19.85B | -2.7% |
| 2017 | $20.41B | +0.7% |
| 2016 | $20.28B | +19.2% |
| 2015 | $17.02B | - |